Correlation Between Gilead Sciences and Psyence Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Gilead Sciences and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Psyence Biomedical.

Diversification Opportunities for Gilead Sciences and Psyence Biomedical

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Gilead and Psyence is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Psyence Biomedical go up and down completely randomly.

Pair Corralation between Gilead Sciences and Psyence Biomedical

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.15 times more return on investment than Psyence Biomedical. However, Gilead Sciences is 6.51 times less risky than Psyence Biomedical. It trades about 0.05 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.1 per unit of risk. If you would invest  7,420  in Gilead Sciences on August 31, 2024 and sell it today you would earn a total of  1,821  from holding Gilead Sciences or generate 24.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Psyence Biomedical Ltd

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
Psyence Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Gilead Sciences and Psyence Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Psyence Biomedical

The main advantage of trading using opposite Gilead Sciences and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.
The idea behind Gilead Sciences and Psyence Biomedical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities